Correction: Characterization of HBV integration patterns and timing in liver cancer and HBV-infected livers

Mayuko Furuta; Hiroko Tanaka; Yuichi Shiraishi; Takuro Uchida; Michio Imamura; Akihiro Fujimoto; Masahi Fujita; Aya Sasaki-Oku; Kazuhiro Maejima; Kaoru Nakano; Yoshiiku Kawakami; Koji Arihiro; Hiroshi Aikata; Masaki Ueno; Shinya Hayami; Shun-Ichi Ariizumi; Masakazu Yamamoto; Kunihito Gotoh; Hideki Ohdan; Hiroki Yamaue; Satoru Miyano; Kazuaki Chayama; Hidewaki Nakagawa

doi:10.18632/oncotarget.25960

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Corrections:

Correction: Characterization of HBV integration patterns and timing in liver cancer and HBV-infected livers

PDF | How to cite

Oncotarget. 2018; 9:31789-31789. https://doi.org/10.18632/oncotarget.25960

Metrics: PDF 1789 views | ?

Mayuko Furuta¹, Hiroko Tanaka², Yuichi Shiraishi², Takuro Uchida³, Michio Imamura³, Akihiro Fujimoto¹, Masahi Fujita¹, Aya Sasaki-Oku¹, Kazuhiro Maejima¹, Kaoru Nakano¹, Yoshiiku Kawakami³, Koji Arihiro⁴, Hiroshi Aikata³, Masaki Ueno⁵, Shinya Hayami⁵, Shun-Ichi Ariizumi⁶, Masakazu Yamamoto⁶, Kunihito Gotoh⁷, Hideki Ohdan⁸, Hiroki Yamaue⁵, Satoru Miyano², Kazuaki Chayama³ and Hidewaki Nakagawa¹

¹ Laboratory for Cancer Genomics, RIKEN Center for Integrative Medical Sciences, Tokyo 108-8639, Japan
² Laboratory of DNA Information Analysis, Human Genome Center, The Institute of Medical Science, The University of Tokyo, Tokyo 108-8639, Japan
³ Department of Gastroenterology and Metabolism, Institute of Biomedical and Health Sciences, Hiroshima University, Hiroshima 734-8551, Japan
⁴ Department of Anatomical Pathology, Institute of Biomedical and Health Sciences, Hiroshima University, Hiroshima 734- 8551, Japan
⁵ Second Department of Surgery, Wakayama Medical University, Wakayama 641-8510, Japan
⁶ Department of Gastroenterological Surgery, Tokyo Women’s Medical University, Tokyo 162-8666, Japan
⁷ Department of Surgery, Osaka International Cancer Institute, Osaka 537-8511, Japan
⁸ Department of Gastroenterological Surgery, Institute of Biomedical and Health Sciences, Hiroshima University, Hiroshima 734-8551, Japan

Published: August 03, 2018

This article has been corrected: The correct author name is given below:

Takuro Uchida

Original article: Oncotarget. 2018; 9:25075-25088. DOI: https://doi.org/10.18632/oncotarget.25308.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 25960

Publication Alerts

Corrections:

Correction: Characterization of HBV integration patterns and timing in liver cancer and HBV-infected livers